Citation: Rg. Larkins et Wp. Anderson, AUSTRALIAN MEDICAL-RESEARCH - MORE RESOURCES AND THE RIGHT BALANCE, Medical journal of Australia, 168(11), 1998, pp. 535-536
Authors:
HOPPER JL
GREEN RM
NOWSON CA
YOUNG D
SHERWIN AJ
KAYMAKCI B
LARKINS RG
WARK JD
Citation: Jl. Hopper et al., GENETIC, COMMON ENVIRONMENT, AND INDIVIDUAL SPECIFIC COMPONENTS OF VARIANCE FOR BONE-MINERAL DENSITY IN 10-YEAR-OLD TO 26-YEAR-OLD FEMALES - A TWIN STUDY, American journal of epidemiology, 147(1), 1998, pp. 17-29
Citation: Rg. Larkins, NEW CONCEPTS FOR TREATMENT OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Trends in endocrinology and metabolism, 8(5), 1997, pp. 187-191
Citation: Rg. Larkins, PROLACTIN-SECRETING PITUITARY-TUMORS WITH MARKED VISUAL-FIELD IMPAIRMENT SHOULD BE TREATED BY BROMOCRIPTINE, Journal of clinical neuroscience, 4(1), 1997, pp. 63-64
Authors:
NOWSON CA
GREEN RM
HOPPER JL
SHERWIN AJ
YOUNG D
KAYMAKCI B
GUEST CS
SMID M
LARKINS RG
WARK JD
Citation: Ca. Nowson et al., A COTWIN STUDY OF THE EFFECT OF CALCIUM SUPPLEMENTATION ON BONE-DENSITY DURING ADOLESCENCE, Osteoporosis international, 7(3), 1997, pp. 219-225
Authors:
FLICKER L
HOPPER JL
LARKINS RG
LICHTENSTEIN M
BUIRSKI G
WARK JD
Citation: L. Flicker et al., NANDROLONE DECANOATE AND INTRANASAL CALCITONIN AS THERAPY IN ESTABLISHED OSTEOPOROSIS, Osteoporosis international, 7(1), 1997, pp. 29-35
Citation: Rj. Keogh et al., EFFECT OF INHIBITION OF ALDOSE REDUCTASE ON GLUCOSE FLUX, DIACYLGLYCEROL FORMATION, PROTEIN-KINASE-C, AND PHOSPHOLIPASE A(2) ACTIVATION, Metabolism, clinical and experimental, 46(1), 1997, pp. 41-47
Citation: De. Myers et al., LIPOPROTEIN-INDUCED PROSTACYCLIN PRODUCTION IN ENDOTHELIAL-CELLS AND EFFECTS OF LIPOPROTEIN MODIFICATION, American journal of physiology. Cell physiology, 40(5), 1996, pp. 1504-1511
Citation: Hd. Yan et al., ROLE OF THE ALDOSE REDUCTASE PATHWAY IN THE PATHOGENESIS OF DIABETIC COMPLICATION, Kidney international, 50(4), 1996, pp. 1404-1405
Authors:
DUNLOP ME
CLARK S
MAHADEVAN P
MUGGLI E
LARKINS RG
Citation: Me. Dunlop et al., PRODUCTION OF HYALURONAN BY GLOMERULAR MESANGIAL CELLS IN RESPONSE TOFIBRONECTIN AND PLATELET-DERIVED GROWTH-FACTOR, Kidney international, 50(1), 1996, pp. 40-44
Authors:
MAHADEVAN P
LARKINS RG
FRASER JRE
DUNLOP ME
Citation: P. Mahadevan et al., EFFECT OF PROSTAGLANDIN E(2) AND HYALURONAN ON MESANGIAL CELL-PROLIFERATION - A POTENTIAL CONTRIBUTION TO GLOMERULAR HYPERCELLULARITY IN DIABETES, Diabetes, 45(1), 1996, pp. 44-50
Authors:
YOUNG D
HOPPER JL
NOWSON CA
GREEN RM
SHERWIN AJ
KAYMAKCI B
SMID M
GUEST CS
LARKINS RG
WARK JD
Citation: D. Young et al., DETERMINANTS OF BONE MASS IN 10-YEAR-OLD TO 26-YEAR-OLD FEMALES - A TWIN STUDY, Journal of bone and mineral research, 10(4), 1995, pp. 558-567
Authors:
MAHADEVAN P
LARKINS RG
FRASER JRE
FOSANG AJ
DUNLOP ME
Citation: P. Mahadevan et al., INCREASED HYALURONAN PRODUCTION IN THE GLOMERULI FROM DIABETIC RATS -A LINK BETWEEN GLUCOSE-INDUCED PROSTAGLANDIN PRODUCTION AND REDUCED SULFATED PROTEOGLYCAN, Diabetologia, 38(3), 1995, pp. 298-305
Citation: Sl. Macaulay et Rg. Larkins, INSULIN STIMULATES TURNOVER OF PHOSPHATIDYLCHOLINE IN RAT ADIPOCYTES, Molecular and cellular biochemistry, 136(1), 1994, pp. 23-28
Citation: Cs. Guest et al., HYPERINSULINEMIA AND OBESITY IN ABORIGINES OF SOUTH-EASTERN AUSTRALIA, WITH COMPARISONS FROM RURAL AND URBAN EUROPID POPULATIONS, Diabetes research and clinical practice, 20(2), 1993, pp. 155-164